CA Stock MarketDetailed Quotes
LSL LSL Pharma Group Inc
- 0.445
- +0.005+1.14%
15min DelayMarket Closed Sep 27 16:00 ET
51.41MMarket Cap-11125P/E (TTM)
0.455High0.430Low46.32KVolume0.450Open0.440Pre Close20.75KTurnover0.55052wk High0.06%Turnover Ratio115.53MShares0.35052wk Low-0.04EPS TTM35.49MFloat Cap1.000Historical HighLossP/E (Static)79.74MShs Float0.350Historical Low-0.11EPS LYR5.68%Amplitude--Dividend TTM2.63P/B1Lot Size--Div YieldTTM
LSL Pharma Group Inc Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 106.05%4.19M | 105.68%4.16M | 22.08%10.03M | 51.03%3.46M | -4.92%2.51M | 43.49%2.03M | 8.51%2.02M | -6.35%8.21M | -7.65%2.29M | 35.61%2.64M |
| Operating revenue | 106.05%4.19M | 105.68%4.16M | 22.08%10.03M | 51.03%3.46M | -4.92%2.51M | 43.49%2.03M | 8.51%2.02M | -6.35%8.21M | -7.65%2.29M | 35.61%2.64M |
| Cost of revenue | 97.84%2.66M | 84.30%3.02M | -19.29%8.38M | -4.77%3.36M | -22.97%2.04M | -23.27%1.34M | -35.48%1.64M | 66.29%10.39M | 101.15%3.53M | 91.45%2.65M |
| Gross profit | 121.97%1.54M | 196.12%1.15M | 175.74%1.65M | 108.04%99.48K | 3,693.42%466.97K | 308.73%692K | 157.60%387K | -186.00%-2.17M | -270.40%-1.24M | -102.32%-13K |
| Operating expense | 23.86%1.66M | -65.29%967K | 22.12%5.6M | -121.02%-185.37K | -27.85%802.91K | 1.89%1.34M | 120.18%2.79M | 76.98%4.59M | -21.79%882.04K | 165.85%1.11M |
| Selling and administrative expenses | 34.52%1.63M | -65.67%933K | 40.85%5.39M | -149.32%-245.3K | -25.03%789.72K | 0.41%1.21M | 159.46%2.72M | 47.79%3.83M | -55.90%497.39K | 151.64%1.05M |
| -Selling and marketing expense | -68.75%20K | 92.86%27K | -9.02%121K | -14.56%-83.53K | -2.58%43.41K | -14.94%64K | -83.74%14K | -39.01%133K | -190.79%-72.92K | -17.88%44.56K |
| -General and administrative expense | 40.30%1.61M | -66.49%906K | 42.64%5.27M | -128.37%-161.77K | -26.02%746.32K | 1.43%1.14M | 181.24%2.7M | 55.77%3.7M | -45.55%570.3K | 176.88%1.01M |
| Research and development costs | -96.97%3K | --0 | -89.54%70K | -125.56%-76.07K | -77.83%13.19K | -12.39%99K | -84.39%34K | --669K | --297.65K | --59.49K |
| Depreciation amortization depletion | -2.94%33K | 0.00%34K | 56.32%136K | ---- | ---- | --34K | --34K | --87K | ---- | ---- |
| -Depreciation and amortization | -2.94%33K | 0.00%34K | 56.32%136K | ---- | ---- | --34K | --34K | --87K | ---- | ---- |
| Operating profit | 80.74%-125K | 107.46%179K | 41.48%-3.95M | 113.44%284.85K | 70.16%-335.95K | 60.61%-649K | -23.84%-2.4M | -10,252.86%-6.76M | -427.59%-2.12M | -888.82%-1.13M |
| Net non-operating interest income (expenses) | -6.70%-414K | -15.04%-459K | -26.70%-1.76M | -51.74%-487.46K | -24.90%-426.07K | -30.44%-388K | -6.18%-399K | 18.73%-1.39M | 27.10%-321.25K | 28.24%-341.14K |
| Non-operating interest expense | 4.37%382K | 21.86%446K | 23.82%1.57M | 7.00%590.73K | 89.78%357.07K | 23.04%366K | -2.60%366K | -20.10%1.27M | 2.47%552.08K | -50.47%188.16K |
| Total other finance cost | 45.45%32K | -60.61%13K | 57.63%186K | 55.26%-103.26K | -54.90%69K | --22K | --33K | -0.42%118K | -135.45%-230.82K | 60.09%152.99K |
| Other net income (expenses) | 23K | -3,509.88%-2.76M | 52.54%-273.33K | -250 | -2.61M | -42.68%81K | -57,594,400.00%-575.94K | |||
| Gain on sale of security | ---- | ---- | 66.89%-50K | ---- | ---- | ---- | ---55K | ---151K | ---- | ---- |
| Special income (charges) | --23K | --0 | -1,268.97%-2.71M | 47.44%-223.33K | ---250 | --0 | ---2.55M | 64.16%232K | -42,494,400.00%-424.94K | --0 |
| -Less:Restructuring and mergern&acquisition | ---23K | --0 | 538.12%2.71M | -47.45%223.33K | --250 | --0 | --2.55M | --425K | --425K | --0 |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -364.90%-657K | -5,600.00%-57 | ---- |
| Income before tax | 50.24%-516K | 94.82%-280K | -5.09%-8.47M | 84.22%-475.95K | 48.04%-762.27K | 22.53%-1.04M | -133.60%-5.4M | -394.76%-8.06M | -258.08%-3.02M | -340.97%-1.47M |
| Income tax | 0 | 0 | 0 | 0 | ||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 50.24%-516K | 94.82%-280K | -5.09%-8.47M | 84.22%-475.95K | 48.04%-762.27K | 22.53%-1.04M | -133.60%-5.4M | -353.71%-8.06M | -151.70%-3.02M | -693.08%-1.47M |
| Net income continuous operations | 50.24%-516K | 94.82%-280K | -5.09%-8.47M | 84.22%-475.95K | 48.04%-762.27K | 22.53%-1.04M | -133.60%-5.4M | -353.71%-8.06M | -151.70%-3.02M | -693.08%-1.47M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 50.24%-516K | 94.82%-280K | -5.09%-8.47M | 84.22%-475.95K | 48.04%-762.27K | 22.53%-1.04M | -133.60%-5.4M | -353.71%-8.06M | -151.70%-3.02M | -693.08%-1.47M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 50.24%-516K | 94.82%-280K | -5.09%-8.47M | 84.22%-475.95K | 48.04%-762.27K | 22.53%-1.04M | -133.60%-5.4M | -353.71%-8.06M | -151.70%-3.02M | -693.08%-1.47M |
| Diluted earnings per share | 51.22%-0.0049 | 95.86%-0.0033 | -12.19%-0.11 | 72.74%-0.01 | 10.45%-0.01 | 1.85%-0.01 | -354.39%-0.08 | -624.87%-0.098 | -302.16%-0.0367 | -693.11%-0.0112 |
| Basic earnings per share | 61.22%-0.0049 | 95.86%-0.0033 | -12.19%-0.11 | 72.74%-0.01 | 10.45%-0.01 | -23.47%-0.0126 | -354.39%-0.08 | -624.87%-0.098 | -302.16%-0.0367 | -693.11%-0.0112 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data